{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:50:33Z","timestamp":1781614233514,"version":"3.54.5"},"reference-count":32,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1695,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1111\/j.1399-0004.2010.01609.x","type":"journal-article","created":{"date-parts":[[2010,12,13]],"date-time":"2010-12-13T14:36:16Z","timestamp":1292250976000},"page":"403-412","source":"Crossref","is-referenced-by-count":30,"title":["Personalized medicine - the promised land: are we there yet?"],"prefix":"10.1111","volume":"79","author":[{"given":"C","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,1,10]]},"reference":[{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration.","volume":"308","author":"Edwards","year":"2005","journal-title":"Science"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/ng1890","article-title":"A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration.","volume":"38","author":"Hughes","year":"2006","journal-title":"Nat Genet"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.genom.9.081307.164350","article-title":"Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration.","volume":"10","author":"Swaroop","year":"2009","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/jhg.2010.19","article-title":"The pursuit of genome-wide association studies: where are we now?","volume":"55","author":"Ku","year":"2010","journal-title":"J Hum Genet"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/jhg.2010.55","article-title":"The discovery of human genetic variations & their use as disease makers: past, present & future.","volume":"55","author":"Ku","year":"2010","journal-title":"J Hum Genet"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.genom.9.081307.164255","article-title":"Genetic screening for low-penetrance variants in protein-coding genes.","volume":"10","author":"Waalen","year":"2009","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1001\/jama.285.17.2216","article-title":"Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States.","volume":"285","author":"Steinberg","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB8|cit8","unstructured":"Hemochromatosis http:\/\/digestive.niddk.nih.gov\/ddiseases\/pubs\/hemochromatosis\/"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrg2735","article-title":"Personalized genomic information: preparing for the future of genetic medicine.","volume":"11","author":"Guttmacher","year":"2010","journal-title":"Nat Rev Genet"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/01.gim.0000232582.91028.03","article-title":"Expanding the definition of a positive family history for early-onset coronary heart disease.","volume":"8","author":"Scheuner","year":"2006","journal-title":"Genet Med"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-a and ribavirin therapy.","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-a and ribavirin therapy for chronic hepatitis C.","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/461357a","article-title":"Hepatitis C gets personal.","volume":"461","author":"Iadonato","year":"2009","journal-title":"Nature"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1093\/hmg\/ddn250","article-title":"Genome-based prediction of common diseases: advances and prospects.","volume":"17","author":"Janssens","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB16|cit16","unstructured":"Green ED. The genomic landscape: circa 2010 in Current Topics in Genome Analysis. http:\/\/genome.gov\/12514288"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB17|cit17","unstructured":"Moline J Eng C. Multiple endocrime neoplasia type 2. In GeneReview. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1257\/"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB18|cit18","unstructured":"Lohmann D Gallie B. http:\/\/www.ncbi.nlm.nih.gov\/book\/NBK1452"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.gene.2004.11.003","article-title":"Eighty percent of proteins are different between humans and chimpanzees.","volume":"346","author":"Glazko","year":"2005","journal-title":"Gene"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1101\/gr.095026.109","article-title":"Recent de novo origin of human protein-coding genes.","volume":"19","author":"Knowles","year":"2009","journal-title":"Genome Res"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature07540","article-title":"A core gut microbiome in obese and lean twins.","volume":"457","author":"Turnbaugh","year":"2009","journal-title":"Nature"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-4419-6033-7_4","article-title":"Genetic and genomics of neuroblastoma.","volume":"155","author":"Capasso","year":"2010","journal-title":"Cancer Treat Res"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/BJ20090387","article-title":"Anaplastic lymphoma kinase: singling in development and disease.","volume":"420","author":"Palmer","year":"2009","journal-title":"Biochem J"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1074\/mcp.M700498-MCP200","article-title":"An integrated, directed mass spectrometric approach for in-depth characterization of complex peptide mixtures.","volume":"7","author":"Schmidt","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/jcb.22378","article-title":"Bevacizumab and ranibizumab on microvascular endothelial cells: a comparative study.","volume":"108","author":"Costa","year":"2009","journal-title":"J Cell Biochem"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2009.03992.x","article-title":"Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy.","volume":"158","author":"Martinelli","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/cncr.24088","article-title":"Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapy.","volume":"115","author":"Peeters","year":"2009","journal-title":"Cancer"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1158\/1078-0432.CCR-07-1569","article-title":"Diagnostic markers for early detection of ovarian cancer.","volume":"14","author":"Visintin","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1073\/pnas.0510921103","article-title":"Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray.","volume":"103","author":"Zhu","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"R180","DOI":"10.1093\/hmg\/ddn253","article-title":"The regulation of direct-to-consumer genetic tests.","volume":"17","author":"Kaye","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/ejhg.2008.254","article-title":"Personal genomics services: whose genomes?","volume":"17","author":"Gurwitz","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1111\/j.1399-0004.2010.01609.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dym056","article-title":"Commentary: the ubiquity of prostate cancer: echoes of the past, implications for the present: \u201cwhat has been will be again, what has been done will be done again; there is nothing new under the sun.\u201d ECCLESIASTES 1:9.","volume":"36","author":"Thompson","year":"2007","journal-title":"Int J Epidemiol"}],"container-title":["Clinical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0004.2010.01609.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1399-0004.2010.01609.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T04:31:25Z","timestamp":1625632285000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0004.2010.01609.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,10]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1399-0004.2010.01609.x","relation":{},"ISSN":["0009-9163"],"issn-type":[{"value":"0009-9163","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,10]]}}}